On December 22, 2017 CureVac AG, a clinical-stage biopharmaceutical company pioneering mRNA-based drugs, reported that it will present at the 2018 J.P. Morgan 36th Annual Healthcare Conference to be held January 8-12, 2018 at the Westin St. Francis Hotel in San Francisco, CA. The presentation will be delivered by Ingmar Hoerr, Ph.D., co-founder and CEO of CureVac AG (Press release, CureVac, DEC 22, 2017, View Source [SID1234522765]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of CureVac’s presentation are as follows:

Event: J.P. Morgan 36th Annual Healthcare Conference
Date: January 10, 2018
Time: 8:00 – 8:25 AM (Pacific Time) / 5:00 – 5:25 PM (Eastern Standard Time)

A live webcast of the presentation will be available here for replay following the event.

Further information on the 2018 J.P. Morgan 36th Annual Healthcare Conference can be found here.